Resumen | Large-scale worldwide COVID-19 vaccination programs are being rapidly deployed. Many patients with malignancy, a high-risk group, have recently had the first dose of the vaccine. A 75-year-old male with prostate cancer and biochemical recurrence underwent [18F]Choline PET/CT for disease assessment. No choline avid malignancy was identified; however, avid left axillary nodes were noted. |
---|---|
Procedencia del autor |
Texto completo |
---|
Tipo de documento | |
---|---|
Especialidad(es) |
Publicado en el sitio | 2021-03-31 18:58:08 |
---|
(aún no hay comentarios disponibles para este recurso)
Comentarios